BenevolentAI

Website: BenevolentAI
Description: 

Benevolent AI is developing artificial intellegence for scientific innovation.

In response to the global coronavirus pandemic, BenevolentAI announced that baricitinib is entering clinical testing as a potential treatment for COVID-19. BenevolentAI identified the drug in recent research by using artificial intelligence and machine learning. The trial by Eli Lilly will investigate the drug’s efficacy and safety.

 

Career Page(s): 
Location(s): 
London
United Kingdom
Cambridge
United Kingdom
New York NY
United States